NYSEMKT: AIMAim Immunotech Inc Earnings Dates, Reports, Calls
Aim Immunotech earnings were -$14.3M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest AIM earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$3.8M, up 25.3% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, AIM reported annual earnings of -$14.0M, with -19.4% growth.
AIM earnings history
Current Revenue
$95.0k
Current Earnings
-$14.3M
Current Profit Margin
-15,021.1%
AIM Return on Equity
Current Company
N/A
Current Industry
-13.6%
Current Market
30.9%
AIM Return on Assets
Current Company
-175.1%
Current Industry
-10.3%
AIM is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance
Be the first to know when AIM announces earnings.
AIM Return on Capital Employed
Current Company
-168.68%
Current Industry
-7%
AIM's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance
AIM vs Biotech Stocks
Aim Immunotech Earnings Reports & History FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.